Back to search

University of British Columbia

Predicting binding affinities of a novel polymer for the neutralization of fondaparinux

Abstract

dc:description

Anticoagulants are an essential clinical tool in modern medicine where they are administered to patients who are undergoing procedures such as cardiac surgery and kidney dialysis. They are also used to treat serious illnesses including venous thromboembolism, unstable angina, and acute myocardial infarction. However, anticoagulants have undesirable side effects, most notably excessive bleeding. Thus, antidotes are required to rapidly reverse the anticoagulant effect and treat life-threatening bleeding complications that might arise from an overdose of anticoagulants or the urgent need to perform an invasive procedure. For instance, while the synthetic anticoagulant fondaparinux has become increasingly important in clinical medicine because of its advantages over other heparin-based drugs, its use is limited by a lack of an antidote. The development of an effective, clinically safe antidote for fondaparinux is therefore critical for its widespread adoption in clinical medicine. The synthetic polymer HBSPCM (Heparin Binding Synthetic Polyvalent Cationic Macromolecule) has been found to be a promising candidate antidote for fondaparinux. However, an optimal design of HBSPCM that binds to fondaparinux with high affinity and neutralizes it has not yet been determined. A robust model is herein developed that describes the electrostatic interactions between fondaparinux and candidate HBSPCMs using data gathered from experimental work as well as molecular dynamics (MD) simulations. This model is then used to characterize the binding affinities of various putative HBSPCM structures for fondaparinux. This enables the prediction of an improved structure for the initial design of an antidote molecule. The synthesis and testing of every possible candidate HBSPCM structure would be costly and time-consuming. By quickly and efficiently predicting molecular structures that show promising binding affinities to fondaparinux, the mathematical model described in this thesis is a vast improvement over a traditional trial-and-error approach to drug design. As such, it represents an essential theoretical tool in the development of fondaparinux as an effective and safe anticoagulation treatment.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor dc:publisher
University of British Columbia
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cajiao, Adriana

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/43760

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Cajiao, Adriana. Predicting binding affinities of a novel polymer for the neutralization of fondaparinux. doctoral thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/43760